QOL Assessment in Cancer Survivors Integrated Into Routine Clinical Care

NCT ID: NCT03835052

Last Updated: 2021-04-02

Basic Information

• Recruitment Status: TERMINATED
• Total Enrollment: 500 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2018-10-01
• Study Completion Date: 2020-03-30

Brief Summary

This observational cohort study of patients who received cancer treatment (of any modality) in the last 18 months are evaluated by the use of a validated QOL tool (FACT-GP) and are evaluated via telephone or in person or both. Patients with high-risk for unmet needs or distress as determined by the FACT-GP are referred to an in-person Multidisciplinary Cancer Survivorship Clinic. This is considered standard of care at the investigator's institution and is part of the continuous clinical quality improvement program within the Geisinger Cancer Institute.

Conditions

Cancer

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Diagnosis of malignancy in the last 18 months, treated with curative intent

Exclusion Criteria

• Patients treated with palliative intent, metastatic disease at the time of diagnosis

• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Geisinger Clinic

OTHER

Sponsor Role: lead

Responsible Party

Christian S. Adonizio, MD

Medical Director: Center for Oncology Research and Innovation

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Christian S Adonizio, MD

Role: STUDY_CHAIR

Geisinger Clinic

Locations

Geisinger Medical Center

Danville, Pennsylvania, United States

Countries

United States

Other Identifiers

2018-0568

Identifier Type: -

Identifier Source: org_study_id